Sonnet BioTherapeutics Holdings, Inc.
SONN · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,776 | -$3,491 | -$3,161 | -$3,129 |
| Dep. & Amort. | $22 | $22 | $22 | $22 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $60 | -$171 |
| Change in WC | $1,856 | $510 | $156 | -$124 |
| Other Non-Cash | $138 | $487 | $12 | $231 |
| Operating Cash Flow | -$1,759 | -$2,471 | -$2,910 | -$3,170 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$12 | $0 | $0 |
| Investing Cash Flow | $0 | -$12 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $41 | $51 | $7,711 | -$7 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$20 | -$370 | -$89 | -$213 |
| Financing Cash Flow | $21 | -$319 | $7,622 | -$235 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,738 | -$2,802 | $4,712 | -$3,405 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,059 | $4,862 | $149 | $3,554 |
| End Cash | $321 | $2,059 | $4,862 | $149 |
| Free Cash Flow | -$1,759 | -$2,471 | -$2,910 | -$3,170 |